These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35076366)

  • 1. Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia.
    Krieger E; Kudryavtsev A; Sharashova E; Postoev V; Belova N; Shagrov L; Zvedina J; Drapkina O; Kontsevaya A; Shalnova S; Brenn T; Shkolnikov VM; Eggo RM; Leon DA
    Emerg Infect Dis; 2022 Feb; 28(2):463-465. PubMed ID: 35076366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan.
    Moser W; Fahal MAH; Abualas E; Bedri S; Elsir MT; Mohamed MFERO; Mahmoud AB; Ahmad AII; Adam MA; Altalib S; DafaAllah OA; Hmed SA; Azman AS; Ciglenecki I; Gignoux E; González A; Mwongera C; Miranda MA
    Emerg Infect Dis; 2022 May; 28(5):1026-1030. PubMed ID: 35450565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 B.1.619 and B.1.620 Lineages, South Korea, 2021.
    Park AK; Kim IH; Man Kim H; Lee H; Lee NJ; Kim JA; Woo S; Lee CY; Lee J; Oh SJ; Rhee J; Yoo CK; Kim EJ
    Emerg Infect Dis; 2022 Feb; 28(2):415-419. PubMed ID: 35076365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19: seroprevalence and adherence to preventive measures in Arkhangelsk, Northwest Russia.
    Krieger E; Sharashova E; Kudryavtsev AV; Samodova O; Kontsevaya A; Brenn T; Postoev V
    Infect Dis (Lond); 2023 May; 55(5):316-327. PubMed ID: 36919829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic.
    Popova AY; Smirnov VS; Andreeva EE; Babura EA; Balakhonov SV; Bashketova NS; Bugorkova SA; Bulanov MV; Valeullina NN; Vetrov VV; Goryaev DV; Detkovskaya TN; Ezhlova EB; Zaitseva NN; Istorik OA; Kovalchuk IV; Kozlovskikh DN; Kombarova SY; Kurganova OP; Lomovtsev AE; Lukicheva LA; Lyalina LV; Melnikova AA; Mikailova OM; Noskov AK; Noskova LN; Oglezneva EE; Osmolovskaya TP; Patyashina MA; Penkovskaya NA; Samoilova LV; Stepanova TF; Trotsenko OE; Totolian AA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Seroprevalence of anti S1 SARS-CoV-2 antibodies in workers vaccinated with Sputnik V at a public hospital in Buenos Aires].
    Rovere P; Laurelli A; Díaz A; Dabusti G; Valdez P
    Medicina (B Aires); 2021; 81(6):895-901. PubMed ID: 34875585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spread of SARS-CoV-2 Variants on Réunion Island, France, 2021.
    Mercier A; Wilkinson DA; Lebarbenchon C; Mavingui P; Yemadje-Menudier L
    Emerg Infect Dis; 2022 Apr; 28(4):895-898. PubMed ID: 35319434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April-June 2022.
    Kislaya I; Melo A; Barreto M; Henriques C; Aniceto C; Manita C; Ramalhete S; Santos JA; Soeiro S; Rodrigues AP;
    Emerg Infect Dis; 2023 Feb; 29(3):590-594. PubMed ID: 36732078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021.
    Curtis SJ; Shah AW; Ratu A; Wilson DJ; Hill PC; Hulcome P; Gaylard C; Faktaufon D; Cabemaiwai T; Rabukawaqa I; Qoriniasi T; Narayan A; Nakalevu S; Romakin P; Tudravu J; Fong J; Walsh N
    Emerg Infect Dis; 2023 Jan; 29(1):226-228. PubMed ID: 36573643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Infection in a Hippopotamus, Hanoi, Vietnam.
    Bui VN; Dao TD; Tran LH; Vu TT; Nguyen TH; Nguyen GH; Tran KVD; Nguyen HX; Bui AN; Unger F; Nguyen-Viet H; Lee HS
    Emerg Infect Dis; 2023 Mar; 29(3):658-661. PubMed ID: 36823956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Complications after Coronavirus Disease and Seasonal Influenza, South Korea.
    Lee H; Sung HK; Lee D; Choi Y; Lee JY; Lee JY; Oh MD
    Emerg Infect Dis; 2022 Feb; 28(2):347-353. PubMed ID: 35076368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon.
    Ndongo FA; Guichet E; Mimbé ED; Ndié J; Pelloquin R; Varloteaux M; Esemu L; Mpoudi-Etame M; Lamare N; Edoul G; Wouambo RK; Djomsi DM; Tongo M; Tabala FN; Dongmo RK; Diallo MSK; Bouillin J; Thaurignac G; Ayouba A; Peeters M; Delaporte E; Bissek AZ; Mpoudi-Ngolé E
    Emerg Infect Dis; 2022 Jun; 28(6):1233-1236. PubMed ID: 35470795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus Disease Spread during Summer Vacation, Israel, 2020.
    Somekh I; Simões EAF; Somekh E
    Emerg Infect Dis; 2022 Jan; 28(1):188-191. PubMed ID: 34817318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
    Stringhini S; Wisniak A; Piumatti G; Azman AS; Lauer SA; Baysson H; De Ridder D; Petrovic D; Schrempft S; Marcus K; Yerly S; Arm Vernez I; Keiser O; Hurst S; Posfay-Barbe KM; Trono D; Pittet D; Gétaz L; Chappuis F; Eckerle I; Vuilleumier N; Meyer B; Flahault A; Kaiser L; Guessous I
    Lancet; 2020 Aug; 396(10247):313-319. PubMed ID: 32534626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, USA, October 2020-March 2021.
    Giuliano AR; Pilon-Thomas S; Schell MJ; Abrahamsen M; Islam JY; Isaacs-Soriano K; Kennedy K; Dukes CW; Whiting J; Rathwell J; Hensel JA; Mangual LN; Schonbrunn E; Bikowitz M; Grassie D; Yang Y
    Emerg Infect Dis; 2022 Mar; 28(3):556-563. PubMed ID: 35081021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
    Shakiba M; Nazemipour M; Salari A; Mehrabian F; Nazari SSH; Rezvani SM; Ghasempour Z; Heidarzadeh A; Mansournia MA
    Emerg Infect Dis; 2021 Feb; 27(2):636-638. PubMed ID: 33349310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA.
    Dileepan M; Di D; Huang Q; Ahmed S; Heinrich D; Ly H; Liang Y
    Virulence; 2021 Dec; 12(1):1597-1609. PubMed ID: 34125647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022.
    Yamayoshi S; Iwatsuki-Horimoto K; Okuda M; Ujie M; Yasuhara A; Murakami J; Duong C; Hamabata T; Ito M; Chiba S; Kobayashi R; Takahashi S; Mitamura K; Hagihara M; Shibata A; Uwamino Y; Hasegawa N; Ebina T; Izumi A; Kato H; Nakajima H; Sugaya N; Seki Y; Iqbal A; Kamimaki I; Yamazaki M; Kawaoka Y; Furuse Y
    Emerg Infect Dis; 2022 Nov; 28(11):2198-2205. PubMed ID: 36198306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of Case-Based Seroprevalence of SARS-CoV-2 Antibodies in Maricopa County, Arizona.
    Jehn M; Pandit U; Sabin S; Tompkins C; White J; Kaleta E; Dale AP; Ross HM; Mac McCullough J; Pepin S; Kenny K; Sanborn H; Heywood N; Schnall AH; Lant T; Sunenshine R
    Am J Public Health; 2022 Jan; 112(1):38-42. PubMed ID: 34936397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands.
    Petersen MS; Strøm M; Christiansen DH; Fjallsbak JP; Eliasen EH; Johansen M; Veyhe AS; Kristiansen MF; Gaini S; Møller LF; Steig B; Weihe P
    Emerg Infect Dis; 2020 Nov; 26(11):2761-2763. PubMed ID: 32726200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.